{"symbol":"BSX","fiscalQuarter":"Q4-2013","reportDate":"2014-02-04","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2013","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 1.23%","keyNumbers":[{"metric":"EPS","actual":"$0.21","expected":"N/A","surprise":"+9.38%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted the strong performance in key product segments.","They noted ongoing challenges in the market but expressed confidence in future growth."],"summary":"Overall, management conveyed a sense of cautious optimism about the company's direction. They acknowledged market challenges but emphasized their commitment to innovation."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.23%, likely due to the absence of revenue details and forward guidance, which may leave investors uncertain about future performance. The cautious tone from management suggests they are aware of market challenges ahead.","metaDescription":"Boston Scientific (BSX) Q4 2013 earnings: EPS beat by 9.38%. Stock down 1.23%. Full breakdown."}}